Sorafenib suppresses extrahepatic metastasis de novo in hepatocellular carcinoma through inhibition of mesenchymal cancer stem cells characterized by the expression of CD90
Mariko Yoshida(Tokyo Medical University), Shuichi Kaneko(Kanazawa University)
Cited by 34
Related Papers
The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma
|Journal of Hepatology|2013|143
The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: A prospective, multicenter study
|Hepatology Research|2008|142
No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations
|BMC Medical Genetics|2012|41
Peretinoin, an acyclic retinoid, inhibits hepatocarcinogenesis by suppressing sphingosine kinase 1 expression in vitro and in vivo
|Scientific Reports|2017|35
BMP9‐ID1 signaling promotes EpCAM‐positive cancer stem cell properties in hepatocellular carcinoma
|Molecular Oncology|2021|29